Literature DB >> 4875398

Genetic factors in relation to drugs.

J H Peters.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4875398     DOI: 10.1146/annurev.pa.08.040168.002235

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN: 0066-4251            Impact factor:   13.820


× No keyword cloud information.
  10 in total

1.  In Vitro-in Vivo Correlation: An Unrealistic Problem.

Authors:  R Hüttenrauch; P Speiser
Journal:  Pharm Res       Date:  1985-05       Impact factor: 4.200

2.  Pharmacokinetics of isoniazid metabolism in man.

Authors:  G A Ellard; P T Gammon
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 3.  Progress in birth defects research.

Authors:  M R Bernfield
Journal:  Calif Med       Date:  1970-02

4.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

5.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

6.  Antibiotics--blessings and curses.

Authors:  E Jawetz
Journal:  Calif Med       Date:  1970-04

7.  Polymorphic acetylation of sulphamethazine in a Zimbabwe population.

Authors:  C F Nhachi
Journal:  J Med Genet       Date:  1988-01       Impact factor: 6.318

8.  Renal and biliary disposition of dapsone in the dog.

Authors:  J T Biggs; A K Uher; L Levy; R D Gordon; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

9.  An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

Authors:  G A Ellard; P J Jenner; P A Downs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.

Authors:  G A Ellard; P T Gammon
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.